BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 15774774)

  • 21. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
    Kim SJ; Lee HW; Kim DC; Rha SH; Hong SH; Jeong JS
    Pathol Int; 2008 Apr; 58(4):233-8. PubMed ID: 18324916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The histopathologic type of the periampullary tumors. Is it important for survival?
    Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
    Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
    Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
    Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
    Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
    J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
    Sellner FJ; Riegler FM; Machacek E
    Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
    McKenna GJ; Meneghetti A; Chen YL; Mui AL; Ong C; Scudamore CH; McMaster WR; Owen DA; Chung SW
    J Surg Oncol; 2005 Jun; 90(4):239-46. PubMed ID: 15906368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Periampullary carcinoma or tumor of the ampulla of Vater?].
    Vasilescu C; Herlea V; Stoicescu M
    Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important prognostic factors in adenocarcinoma of the ampulla of Vater.
    Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
    Am Surg; 2009 Sep; 75(9):754-60; discussion 761. PubMed ID: 19774945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
    Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
    Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
    Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
    Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis.
    Kamisawa T; Fukayama M; Koike M; Tabata I; Egawa N; Isawa T; Okamoto A; Hayashi Y
    Am J Gastroenterol; 1988 Oct; 83(10):1118-23. PubMed ID: 3048082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
    Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
    J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maspin expression in adenocarcinoma of the ampulla of Vater: relation with clinicopathological parameters and apoptosis.
    Blandamura S; D'Alessandro E; Guzzardo V; Giacomelli L; Moschino P; Parenti A; Ninfo V
    Anticancer Res; 2007; 27(2):1059-65. PubMed ID: 17465244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of MUC1 and MUC2 in ampullary cancer.
    Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
    Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.